Original articleImpact of Dry Eye Syndrome on Vision-Related Quality of Life
Section snippets
Study population
The Women’s Health Study (WHS) was a randomized, double-masked, placebo-controlled trial among 39,876 US female health professionals (actively working or retired) ages 39 to 90 years at baseline to assess the benefits and risks of low-dose aspirin and vitamin E in the primary prevention of cardiovascular disease and cancer among healthy women.19, 20 Information on general characteristics of the study population was ascertained on annual questionnaires as has been previously reported.21 The
Study subject’s characteristics
Of the 450 WHS and 240 PHS participants selected, 85% (385 from WHS and 204 from PHS) completed the supplementary DES questionnaire and were included in this analysis. Dry eye was present in 135 women (41 who reported severe symptoms, 62 who had been diagnosed with dry eye, and 31 who had both severe symptoms and a prior diagnosis of dry eye) and 55 men (17 who reported severe symptoms, 25 with diagnosed dry eye, and 13 with both severe symptoms and a prior diagnosis of dry eye). Baseline
Discussion
Dry eye syndrome is a common problem that may often be overlooked clinically because it tends not to be a common cause of permanent visual morbidity as traditionally measured.3 However, the present study suggests that DES can have a significant impact on visual function that can diminish a person’s quality of everyday living. More specifically, the present study shows that crucial daily activities of modern living such as reading, computer use, professional work, driving, and watching
Biljana Miljanović, MD, MPH, MSc, is a Research Fellow at Harvard Medical School and the Division of Aging, Brigham, and Women’s Hospital in Boston, Massachusetts. Dr Miljanović is intrigued by questions of the consequences of modern living, e.g. with industrialized food production and dietary changes, man-made environments, medication use, and how these impact chronic diseases of aging and their consequences.
References (37)
- et al.
Vision loss: a public health problem?
Ophthalmology
(2003) - et al.
Prevalence of dry eye syndrome among US women
Am J Ophthalmol
(2003) - et al.
Prevalence of dry eye among the elderly
Am J Ophthalmol
(1997) - et al.
Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women
Am J Clin Nutr
(2005) - et al.
Impaired functional visual acuity of dry eye patients
Am J Ophthalmol
(2002) - et al.
Utility assessment among patients with dry eye disease
Ophthalmology
(2003) - et al.
Comparing the discriminative validity of two generic and one disease-specific health-related quality of life measures in a sample of patients with dry eye
Value Health
(2005) - et al.
Meta-analysis in clinical trials
Control Clin Trials
(1986) - et al.
The application of a new continuous functional visual acuity measurement system in dry eye syndromes
Am J Ophthalmol
(2005) - et al.
Improved functional visual acuity after punctal occlusion in dry eye patients
Am J Ophthalmol
(2003)
Effect of artificial tears on corneal surface regularity, contrast sensitivity, and glare disability in dry eyes
Ophthalmology
Night vision disturbances after corneal refractive surgery
Surv Ophthalmol
Hormone replacement therapy and dry eye syndrome
JAMA
Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes
CLAO J
Dry eye: prevalence, utilization, and economic implications
Manag Care
Sex steroids, the meibomian gland and evaporative dry eye
Adv Exp Med Biol
Dry eye after LASIK: comparison of outcomes for Asian and Caucasian eyes
Clin Exp Optom
Dry eyes and video display terminals
N Engl J Med
Cited by (0)
Biljana Miljanović, MD, MPH, MSc, is a Research Fellow at Harvard Medical School and the Division of Aging, Brigham, and Women’s Hospital in Boston, Massachusetts. Dr Miljanović is intrigued by questions of the consequences of modern living, e.g. with industrialized food production and dietary changes, man-made environments, medication use, and how these impact chronic diseases of aging and their consequences.
Debra A. Schaumberg, ScD, OD, MPH, is an Associate Professor of Medicine at Harvard Medical School, Clinical Associate Scientist at the Schepens Eye Research Institute, and the Director of Ophthalmic Epidemiology, Division of Preventive Medicine, Brigham and Women’s Hospital, Boston, Massachusetts. Dr Schaumberg principal research interests regard the roles of both environmental and genetic risk factors, and their interactions, in common eye diseases including dry eye syndrome, cataract, macular degeneration, and diabetic retinopathy.